
Semaglutide reduces excess body fat in people with obesity
In adults with obesity or overweight, weekly treatment with the glucagon-like peptide 1 (GLP1) receptor agonist semaglutide leads to reduced excess body fat and increased lean body mass, according to an industry-sponsored ...
Mar 20, 2021
0
30